American Heart Association In Brief: MADIT cost-effectiveness study
This article was originally published in The Gray Sheet
Executive Summary
MADIT cost-effectiveness study: Preliminary results from cost-effectiveness analysis of the multicenter automatic defibrillator implantation trial (MADIT) suggest that implantable cardiac defibrillators "may represent a relatively modest investment in terms of years of life saved," University of Rochester Medical Center researchers report at AHA. The per-patient ICD cost-effectiveness ratio of $31,000 per life year saved (90% confidence level, range $74,000 to $10,000) "compares quite favorably to other cardiac interventions," researchers state. Initial MADIT results, showing that ICD therapy is beneficial in patients who have experienced myocardial infarction and nonsustained runs of ventricular tachycardia but no cardiac death or sustained tachycardia, were presented at the North American Society for Pacing and Electrophysiology meeting in May ("The Gray Sheet" May 20, I&W-1)...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.